Dave A. Happel Intends to Resign from Horizon Pharma Public Limited Company Effective February 1, 2018 as Executive Vice President, Commercial Development and Strategy
January 24, 2018 at 04:06 pm EST
Horizon Pharma Public Limited Company announced that on January 18, 2018, Dave A. Happel notified the company that he intended to resign from the company, effective February 1, 2018, as Executive Vice President, Commercial Development and Strategy. Mr. Happel has been named Chief Executive Officer of Chrono Therapeutics. The company does not expect to replace the position and Mr. Happel's duties will be assumed by other members of executive team.